Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Outsourcing services are on of the pillars of Merck's business, delivered via its process solutions unit, part of the group's life sciences division. The unit contributed almost €3.4 billion out ...

with trillions spent on life sciences R&D every year to advance new drug discoveries. That R&D takes place not only at big pharma companies—household names such as Pfizer and Merck—but also at smaller ...

The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.

Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 million, it said ahead of its Capital ...

Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...

About the Life Science business of Merck KGaA, Darmstadt ... by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please ...